Sedia Biosciences Expands Its HIV-1 LAg-Avidity Assay for Recent HIV-1 Infections to Dried Blood Spot Specimens

PRESS RELEASE: Sedia Biosciences Corporation of Portland Oregon, USA, announced today the commercial launch of a new product, the Sedia™ HIV-1 Limiting Antigen (LAg)-Avidity EIA for Dried Blood Spot Specimens. The new assay supplements its......